X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (201) 201
oncology (162) 162
female (155) 155
index medicus (152) 152
middle aged (152) 152
aged (131) 131
breast cancer (109) 109
adult (108) 108
cancer (102) 102
lymphatic metastasis (101) 101
prognosis (85) 85
surgery (82) 82
chemotherapy (81) 81
male (76) 76
care and treatment (69) 69
neoplasm staging (69) 69
breast neoplasms - pathology (67) 67
survival (66) 66
radiotherapy (59) 59
chemotherapy, adjuvant (58) 58
treatment outcome (54) 54
lymph nodes - pathology (53) 53
retrospective studies (53) 53
node positive (49) 49
node-positive (48) 48
breast neoplasms - drug therapy (47) 47
carcinoma (47) 47
disease-free survival (46) 46
aged, 80 and over (44) 44
analysis (44) 44
adjuvant chemotherapy (42) 42
breast neoplasms - mortality (42) 42
metastasis (41) 41
survival rate (38) 38
therapy (38) 38
follow-up studies (37) 37
hematology, oncology and palliative medicine (36) 36
survival analysis (35) 35
medicine & public health (34) 34
research (33) 33
node-positive head (32) 32
adjuvant treatment (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
dissection (30) 30
node-positive breast cancer (30) 30
women (30) 30
lymphatic system (28) 28
radiation-therapy (28) 28
risk (28) 28
squamous-cell carcinoma (28) 28
metastases (27) 27
health aspects (26) 26
patients (26) 26
prostate cancer (26) 26
radiation therapy (26) 26
biopsy (25) 25
cyclophosphamide (25) 25
lymph nodes (25) 25
patient outcomes (25) 25
radiotherapy, adjuvant (25) 25
adjuvant therapy (24) 24
lymph node excision (24) 24
radical prostatectomy (24) 24
cancer patients (23) 23
kaplan-meier estimate (23) 23
abridged index medicus (22) 22
breast neoplasms - surgery (22) 22
proportional hazards models (22) 22
radiology, nuclear medicine & medical imaging (21) 21
trial (21) 21
urology & nephrology (21) 21
risk factors (20) 20
adjuvant (19) 19
docetaxel (19) 19
tamoxifen (19) 19
combined modality therapy (18) 18
lymph node positive (18) 18
lymphatic metastasis - pathology (18) 18
management (18) 18
multivariate analysis (18) 18
neoplasm recurrence, local (18) 18
time factors (18) 18
antineoplastic agents - therapeutic use (17) 17
axilla (17) 17
carcinoma, squamous cell - pathology (17) 17
clinical trials (17) 17
neoadjuvant chemotherapy (17) 17
squamous cell carcinoma (17) 17
breast neoplasms - metabolism (16) 16
breast neoplasms - therapy (16) 16
cancer therapies (16) 16
head and neck cancer (16) 16
medical prognosis (16) 16
oncology, experimental (16) 16
predictive value of tests (16) 16
prospective studies (16) 16
radiation (16) 16
randomized-trial (16) 16
adjuvant radiotherapy (15) 15
carcinoma, squamous cell - surgery (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1845 - 1855
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 522 - 530
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1789 - 1801
A blinded trial involving patients with resected stage III melanoma showed that adjuvant pembrolizumab every 3 weeks for a year was associated with a 1-year... 
HIGH-RISK MELANOMA | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ANTI-PD-1 THERAPY | EORTC 18952 | TUMOR BURDEN | CUTANEOUS MELANOMA | PHASE-3 TRIAL | PEGYLATED INTERFERON-ALPHA-2B | NODE-POSITIVE MELANOMA | IPILIMUMAB | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Adjuvants, Immunologic - adverse effects | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Adjuvants, Immunologic - therapeutic use | Skin Neoplasms - surgery | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Survival Rate | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Melanoma - drug therapy | Intention to Treat Analysis | Quality of Life | Aged | B7-H1 Antigen - analysis | Infusions, Intravenous | Melanoma - surgery | Neoplasm Staging | Melanoma - mortality | Diagnosis | Drug therapy | Patients | Health aspects | Melanoma | Medical research | Lymphatic system | Risk groups | PD-1 protein | Committees | Metastasis | Survival | Skin cancer | Pembrolizumab | Hospitals | Motivation | PD-L1 protein | Myositis | Death | Mutation | Tumors | Cancer | Index Medicus | Abridged Index Medicus | Placebos | Placebos (Medicine) | Adjuvant treatment of cancer | Tractament adjuvant del càncer
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 10/2019
Journal Article
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, ISSN 0748-7983, 08/2019
Various options for axillary staging after neoadjuvant systemic therapy (NST) are available for breast cancer patients with a clinically positive axillary node... 
Journal Article
The Oncologist, ISSN 1083-7159, 07/2018, Volume 23, Issue 7, pp. 768 - 775
Background The 21‐gene Recurrence Score (RS) assay is only reimbursed in Ontario for node‐negative and micrometastatic node‐positive (N+) early‐stage breast... 
Adjuvant chemotherapy | Breast cancer | Node positive | Recurrence score | TREATMENT RECOMMENDATIONS | TAMOXIFEN | RISK | SYSTEMIC THERAPY | REGIMENS | CHEMOTHERAPY | ONCOLOGY | EXPRESSION | AMERICAN SOCIETY | Breast Cancer
Journal Article
Annals of Surgery, ISSN 0003-4932, 03/2019, Volume 269, Issue 3, pp. 432 - 442
OBJECTIVE:The aim of this study was to perform a systematic review and meta-analysis to assess the accuracy of different surgical axillary staging procedures... 
Neoadjuvant therapy | Usage | Care and treatment | Breast cancer | Diagnosis | Meta-analysis | Meta-Analysis | sentinel lymph node biopsy | iodine seed | breast cancer | node-positive | neoadjuvant systemic therapy | axillary staging
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 15, pp. 1444 - 1454
Journal Article
European Urology, ISSN 0302-2838, 09/2018, Volume 74, Issue 3, pp. 253 - 256
Using institutional data, we have previously developed an algorithm to identify the optimal candidates for adjuvant radiotherapy (aRT) among men with pN1... 
Adjuvant radiotherapy | Lymph node dissection | Radical prostatectomy | Prostate cancer | Node-positive disease | Lymph node invasion | SURVIVAL | UROLOGY & NEPHROLOGY | IMMEDIATE
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 07/2019, Volume 154, Issue 1, pp. 22 - 28
To identify the optimal adjuvant treatment regimen for patients with endometrioid and non-endometrioid node-positive endometrial cancer. We retrospectively... 
Endometrioid | FIGO stage IIIC endometrial cancer | Node-positive endometrial cancer | Non-endometrioid | Adjuvant therapy | Care and treatment | Endometrial cancer | Adjuvant treatment | Cancer
Journal Article
Annals of Surgery, ISSN 0003-4932, 01/2019, Volume 269, Issue 3, pp. 432 - 442
textabstractObjective: The aim of this study was to perform a systematic review and meta-analysis to assess the accuracy of different surgical axillary staging... 
breast cancer | node-positive | sentinel lymph node biopsy | iodine seed | neoadjuvant systemic therapy | axillary staging | SURGERY | MULTICENTER | FEASIBILITY | MARKING | LYMPH-NODES | BIOPSY | RADIOACTIVE IODINE SEEDS | WIRE LOCALIZATION | PREOPERATIVE CHEMOTHERAPY | CLIPPED NODE
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 11/2019, Volume 29, Issue 9, pp. 1355 - 1360
ObjectiveNodal involvement is one of the most important prognostic factors in cervical cancer patients. We aimed to assess the prognostic role in relation to... 
MANAGEMENT | radiation and chemotherapy | RANDOMIZED-TRIAL | cervical cancer | IFOSFAMIDE | stage IIIC | PACLITAXEL | OBSTETRICS & GYNECOLOGY | node positive | RADICAL SURGERY | CISPLATIN | ONCOLOGY | CARCINOMA
Journal Article